COVID-19 vaccination in the Philippines

COVID-19 vaccination in the Philippines

Logo of Resbakuna,[a] the national COVID-19 vaccination campaign of the Philippines
Date	March 1, 2021 (2021-03-01) – July 22, 2023 (2023-07-22)
Location	Philippines
Cause	COVID-19 pandemic in the Philippines
Target	Achieve herd immunity Fully vaccinate 70% of the population (77.1 million) against COVID-19[1]
Organized by	Department of Health (DOH)
Participants	166,423,405 total doses administered[b]
Outcome	65.16% of the Filipino population has received their first dose of a two-dose vaccine or a single-dose vaccine 67.75% has been fully vaccinated 19.72% has received a booster doses
Website	Department of Health

The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.^[2]

The Food and Drug Administration (FDA) has issued emergency use authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna, Sinopharm BIBP, Sputnik Light and Novavax.

As of February 19, 2023, 166,423,405 total vaccine doses have been administered throughout the country, with 73,873,958 being fully vaccinated, 21,500,083 booster doses administered.

Cite error: There are <ref group=lower-alpha> tags or {{efn}} templates on this page, but the references will not show without a {{reflist|group=lower-alpha}} template or {{notelist}} template (see the help page).